Literature DB >> 9666114

The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization.

Y Liu1.   

Abstract

The hepatocyte growth factor (HGF) receptor is a tyrosine kinase transmembrane protein encoded by the c-met proto-oncogene. Here, we have isolated and characterized human genomic DNA clones containing the entire coding sequence of the HGF receptor. The gene spans approx. 120kb in length and consists of 21 exons interrupted by 20 introns. Two alternative splice sites corresponding to known mRNA transcripts are located at exon 10 and exon 14, respectively. Structural analysis of the 5'-regulatory region reveals that the c-met promoter lacks TATA or CAAT elements but has an extremely high G-C content and multiple Sp1 binding sites. By transfection of a series of chimeric reporter constructs containing a variable region of the c-met promoter and the coding region for chloramphenicol acetyltransferase, we have identified two positive, and one negative regulatory elements that dictate c-met transcription in renal epithelial mIMCD-3 cells at nucleotide positions -2615 to -1621, -223 to -68, and -1621 to -1093, respectively. Moreover, deletion and mutation of the multiple Sp1 sites in the c-met promoter region markedly reduced c-met promoter activity in mIMCD-3 cells, suggesting that the Sp1 sites are essential for establishing the constitutive expression of the c-met gene. These data provide fundamental information on HGF receptor gene organization, as well as on the genomic origin of different receptor isoforms, and should facilitate further studies on the transcriptional regulation of its expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9666114     DOI: 10.1016/s0378-1119(98)00264-9

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  23 in total

Review 1.  Role of MetMAb (OA-5D5) in c-MET active lung malignancies.

Authors:  Mosmi Surati; Premal Patel; Amy Peterson; Ravi Salgia
Journal:  Expert Opin Biol Ther       Date:  2011-12       Impact factor: 4.388

2.  Regulation of MET by FOXP2, genes implicated in higher cognitive dysfunction and autism risk.

Authors:  Zohar Mukamel; Genevieve Konopka; Eric Wexler; Gregory E Osborn; Hongmei Dong; Mica Y Bergman; Pat Levitt; Daniel H Geschwind
Journal:  J Neurosci       Date:  2011-08-10       Impact factor: 6.167

Review 3.  MET targeted therapy for lung cancer: clinical development and future directions.

Authors:  Yan Feng; Patrick C Ma
Journal:  Lung Cancer (Auckl)       Date:  2012-08-09

4.  Biological roles of hepatocyte growth factor-Met signaling from genetically modified animals.

Authors:  Takashi Kato
Journal:  Biomed Rep       Date:  2017-10-18

5.  Special issue: "MET as actionable target in cancer therapy".

Authors:  Patrick C Ma
Journal:  Ann Transl Med       Date:  2017-01

Review 6.  Biology of MET: a double life between normal tissue repair and tumor progression.

Authors:  Iacopo Petrini
Journal:  Ann Transl Med       Date:  2015-04

Review 7.  Targeting MET in Lung Cancer: Will Expectations Finally Be MET?

Authors:  Alexander Drilon; Federico Cappuzzo; Sai-Hong Ignatius Ou; D Ross Camidge
Journal:  J Thorac Oncol       Date:  2016-10-26       Impact factor: 15.609

8.  DNA triplex-mediated inhibition of MET leads to cell death and tumor regression in hepatoma.

Authors:  G Singhal; M Z Akhter; D F Stern; S D Gupta; A Ahuja; U Sharma; N R Jagannathan; M R Rajeswari
Journal:  Cancer Gene Ther       Date:  2011-06-10       Impact factor: 5.987

9.  Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy.

Authors:  Junwei Yang; Ryan W Shultz; Wendy M Mars; Rodney E Wegner; Yingjian Li; Chunsun Dai; Kari Nejak; Youhua Liu
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

10.  MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis.

Authors:  Ulrike Stein; Wolfgang Walther; Franziska Arlt; Holger Schwabe; Janice Smith; Iduna Fichtner; Walter Birchmeier; Peter M Schlag
Journal:  Nat Med       Date:  2008-12-21       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.